Records containing: Psoriasis

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2012-11-29
  An Australian Cross-Sectional Epidemiological Study To Evaluate The Prevalence Of Undiagnosed Psoriatic Arthritis In Psoriasis Patients In Dermatology Practice Focusing On Disease Severity, Disease Burden And Quality Of Life
• CLINICAL_TRIALS study record update · 2012-11-21
  A Phase 3, Multicenter, Randomized Study Comparing CNTO 1275 and Etanercept for the Treatment of Moderate to Severe Plaque Psoriasis
• CLINICAL_TRIALS study record update · 2012-11-02
  A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of CNTO 1275 in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis.
• CLINICAL_TRIALS study record update · 2012-11-02
  A Randomized, Placebo-controlled, Ascending Single-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KHK4827 in Healthy Volunteers and Subjects With Moderate to Severe Psoriasis
• CLINICAL_TRIALS study record update · 2012-10-29
  Real-World Assessment of Long-Term Infliximab Therapy for Psoriasis
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2012-10-11
  To Observe the Effectiveness and Safety of Anti-TNFs in Patients With Moderate to Severe Psoriasis
• CLINICAL_TRIALS study record update · 2012-10-05
  A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Korean and Taiwanese Subjects With Moderate to Severe Plaque-type Psoriasis
• CLINICAL_TRIALS study record update · 2012-09-28
  A Phase 2 Dose-Randomized, Vehicle-Controlled Study of PH-10-Aqueous Hydrogel for the Treatment of Plaque Psoriasis
• CLINICAL_TRIALS study record update · 2012-09-14
  A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Chinese Subjects With Moderate to Severe Plaque-type Psoriasis
• CLINICAL_TRIALS study record update · 2012-09-12
  Post Marketing Surveillance Study of the Labeled Use of Remicade® (Infliximab) in Patients With Chronic Inflammatory Diseases
• CLINICAL_TRIALS study record update · 2012-08-24
  A Phase 3, Multicenter, Randomized, Double-blind, Placebo Controlled Trial Evaluating the Efficacy and Safety of Ustekinumab (CNTO 1275) in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
• CLINICAL_TRIALS study record update · 2012-08-23
  A 12-Week, Exploratory, Open-Label, Nonrandomized, Dose-Escalation Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe, Recalcitrant, Plaque Type Psoriasis
• CLINICAL_TRIALS study record update · 2012-08-22
  Can We Miss Pigmented Lesions in Psoriasis Patients?
• CLINICAL_TRIALS study record update · 2012-08-06
  Production of Antibodies Against Tnf-alfa Blockers in Patients With Psoriasis
• CLINICAL_TRIALS study record update · 2012-08-03
  Long-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type Psoriasis
• CLINICAL_TRIALS study record update · 2012-07-26
  A Study of Dose Optimization of Infliximab in the Treatment of Moderate to Severe Plaque Psoriasis
• CLINICAL_TRIALS study record update · 2012-07-06
  Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis
• CLINICAL_TRIALS study record update · 2012-06-26
  A Randomized, Double-Blind, , Placebo Controlled, 18 Week Study To Evaluate the Efficacy of Adjuvant 9-cis-β-Carotene Rich Powder of the Alga Dunaliella Bardawil in Subjects With Plaque Type Psoriasis.
• CLINICAL_TRIALS study record update · 2012-06-21
  Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice
• CLINICAL_TRIALS study record update · 2012-04-23
  A Randomized, Double-Blind Trial Assessing the Efficacy and Safety of Etanercept 50 mg Twice Weekly and Etanercept 50 mg Once Weekly for the Treatment of Moderate to Severe Psoriasis
• CLINICAL_TRIALS study record update · 2012-04-23
  A Randomized Pilot Study Evaluating the Efficacy and Safety of Etanercept in Patients With Moderate to Severe Plaque Psoriasis After Cessation of Ciclosporin Therapy
• CLINICAL_TRIALS study record update · 2012-04-19
  A Phase 2a, Open Label, Multiple-Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Teplizumab in Adults With Moderate or More Severe Psoriasis
• CLINICAL_TRIALS study record update · 2012-04-04
  Effect of Weight Loss on Skin Manifestations, Inflammatory Markers and Risk Factor for Comorbidity in Obese Patients With Psoriasis - a Randomized Cross-over Study
• CLINICAL_TRIALS study record update · 2012-03-30
  A 3 Month, Randomised, Open Label, Parallel Group, Descriptive Study to Explore and Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept (Etanercept Auto-injector and the Etanercept Prefilled Syringe) in Patients With Psoriasis.
• CLINICAL_TRIALS study record update · 2012-03-16
  Adalimumab in Primary Combination With UVB-311nm Half-side Phototherapy in Patients With Psoriasis